Latest Healthcare Research Reports

Tag: cancer vaccines market trends

Key Insights into the Cancer Vaccines Market: Trends, Growth Rate, and Opportunities Through 2034

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theCancer Vaccines Market?

The rising global cancer incidence is also expected to contribute to the growth of the cancer vaccines market. In 2022, the American Cancer Society predicted 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the U.S. alone. The four most prevalent cancers globally—lung, prostate, bowel, and breast cancer—account for a significant portion of new cancer cases. The increasing global cancer rates are expected to drive higher demand for cancer vaccines in the coming years.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

#How Does the ProjectedCancer Vaccines Market Growth Compare Over the Forecast Period?

The cancer vaccines market size has grown rapidly in recent years. It will grow from $7.22 billion in 2024 to $8.25 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth is driven by the rising incidence of cancer, expanding approval of cancer vaccines, growing evidence of their efficacy, and government support for research and development.

The cancer vaccines market is set for rapid growth, reaching $13.89 billion by 2029 at a CAGR of 13.9%. The expansion is attributed to combination therapies, increased pharmaceutical investments, emerging biomarkers, personalized vaccines, and expanding vaccination programs. Trends include advancements in immunology, adjuvant therapies, diversification of vaccine indications, patient access, collaborative research, and neoantigen-based vaccines.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3452

How Are Market Trends and Innovations Revolutionizing theCancer Vaccines Industry in Recent Times?

Rising global interest in natural remedies is also expected to affect sales in the cancer vaccines market. Approaches such as Ayurveda, yoga, acupuncture, and sujok therapy are gaining traction and slowly displacing conventional hospital treatments. Ayurvedic methods in particular use a variety of herbal treatments for cancer. As noted by the WHO, many countries continue to rely on plant-based medicine. The homeopathic products market is also forecasted to reach $18.6 billion by 2027. These trends are likely to reduce the demand for cancer vaccines over time.

Who Are the Dominant Market Players Pushing the Boundaries of theCancer Vaccines Market?

Major companies operating in the cancer vaccines market include GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc.

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

What Are the Core Segments of the Cancer Vaccines Market, and How Do They Contribute to Growth?

The cancer vaccines market covered in this report is segmented –

1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types

4) By End-User: Cancer Treatment Centers, Research Institutes

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines

2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3452&type=smp

What Regions Are Dominating the Cancer Vaccines Market Growth?

The countries covered in the cancer vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Browse Through More Reports Similar to the Global Cancer Vaccines Market 2025, By The Business Research Company:

Cancer biologics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

May 12, 2025
How is the Cancer Vaccines Market Poised for Growth: Trends and Opportunities Through 2034

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cancer vaccines market grown over the years?

In recent times, the market size for cancer vaccines has seen a substantial growth. It’s projected to increase from $7.22 billion in 2024, reaching $8.25 billion by the year 2025, maintaining a compound annual growth rate (CAGR) of 14.3%. The growth observed in the historical period is due to factors such as a surge in cancer cases, an increase in awareness about cancer vaccines, the expansion of the array of approved cancer vaccines, mounting proof of the effectiveness of such vaccines, and governmental backing for research and development activities.

What Is the forecasted market size and growth rate for the cancer vaccines market?

Over the coming years, the market size for cancer vaccines is predicted to witness swift expansion. It is slated to reach $13.89 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.9%. The progression during the forecast period is largely due to the adoption of combination therapies involving cancer vaccines, greater funding by pharmaceutical firms, the emergence of biomarkers, personalized vaccines, and the spread of vaccination programs. Key trends expected in the forecast period encompass progress in immunology, application of adjuvant therapies, diversification of indications, patient accessibility, cooperative research, neoantigen-focused vaccines, and treatment-oriented cancer vaccines.

Get your cancer vaccines market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

What are the major factors driving growth in the cancer vaccines market?

Rising cancer incidents worldwide are predicted to bolster the growth of the global cancer vaccines market in the future. Specifically, the American Cancer Society stated in January 2022 that an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths are expected in the US, equating to about 1,670 deaths each day. Globally, the four most prevalent cancers are lung, prostate, bowel, and female breast cancer, which together account for 43% of all fresh cancer cases. Thus, the increasing global incidence of cancer is expected to stimulate higher demand in the cancer vaccine market in the approaching years.

What key areas define the segmentation of the global cancer vaccines Market?

The cancer vaccines market covered in this report is segmented –

1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types

4) By End-User: Cancer Treatment Centers, Research Institutes

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines

2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

What are the top market players propelling the growth of the cancer vaccines industry?

Major companies operating in the cancer vaccines market include GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc.

What are the key trends shaping the future of the cancer vaccines market?

The growing popularity of alternative therapies and natural remedies worldwide is predicted to negatively impact the profit margins of businesses that manufacture cancer vaccines. Various treatment modalities including homeopathy, Ayurveda, yoga, acupuncture, and sujok therapy seem to be progressively substituting some conventional hospital systems. For example, Ayurveda, a time-honored Indian medicinal system, incorporates a variety of methods and treatments to deal with cancer. As per the World Health Organization (WHO), several countries continue to rely on plant-derived treatments as their primary source of medication, and developing countries harness the advantages of natural compounds for healing purposes, resulting in reduced cancer vaccine sales. Moreover, the worldwide market for homeopathic products is expected to hit $18.6 billion by late 2027. This tendency is anticipated to persist throughout the projection period, thereby curtailing the demand for cancer vaccines.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3452

What regions are dominating the cancer vaccines market growth?

North America was the largest region in the cancer vaccines market in 2024. The regions covered in the cancer vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Cancer biologics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

March 21, 2025
How is the Cancer Vaccines Market Poised for Growth: Trends and Opportunities Through 2034

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Cancer Vaccines Market Over the Coming Decade?

In recent times, the market size for cancer vaccines has seen a substantial growth. It’s projected to increase from $7.22 billion in 2024, reaching $8.25 billion by the year 2025, maintaining a compound annual growth rate (CAGR) of 14.3%. The growth observed in the historical period is due to factors such as a surge in cancer cases, an increase in awareness about cancer vaccines, the expansion of the array of approved cancer vaccines, mounting proof of the effectiveness of such vaccines, and governmental backing for research and development activities.

Over the coming years, the market size for cancer vaccines is predicted to witness swift expansion. It is slated to reach $13.89 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.9%. The progression during the forecast period is largely due to the adoption of combination therapies involving cancer vaccines, greater funding by pharmaceutical firms, the emergence of biomarkers, personalized vaccines, and the spread of vaccination programs. Key trends expected in the forecast period encompass progress in immunology, application of adjuvant therapies, diversification of indications, patient accessibility, cooperative research, neoantigen-focused vaccines, and treatment-oriented cancer vaccines.

What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Cancer Vaccines Market?

Rising cancer incidents worldwide are predicted to bolster the growth of the global cancer vaccines market in the future. Specifically, the American Cancer Society stated in January 2022 that an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths are expected in the US, equating to about 1,670 deaths each day. Globally, the four most prevalent cancers are lung, prostate, bowel, and female breast cancer, which together account for 43% of all fresh cancer cases. Thus, the increasing global incidence of cancer is expected to stimulate higher demand in the cancer vaccine market in the approaching years.

Explore Comprehensive Insights Into The Global Cancer Vaccines Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

What Are the Major Players Making an Impact in the Cancer Vaccines Market’s Growth?

Major companies operating in the cancer vaccines market include GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc.

What Are the Key Emerging Trends in the Cancer Vaccines Market for the Next Decade?

The growing popularity of alternative therapies and natural remedies worldwide is predicted to negatively impact the profit margins of businesses that manufacture cancer vaccines. Various treatment modalities including homeopathy, Ayurveda, yoga, acupuncture, and sujok therapy seem to be progressively substituting some conventional hospital systems. For example, Ayurveda, a time-honored Indian medicinal system, incorporates a variety of methods and treatments to deal with cancer. As per the World Health Organization (WHO), several countries continue to rely on plant-derived treatments as their primary source of medication, and developing countries harness the advantages of natural compounds for healing purposes, resulting in reduced cancer vaccine sales. Moreover, the worldwide market for homeopathic products is expected to hit $18.6 billion by late 2027. This tendency is anticipated to persist throughout the projection period, thereby curtailing the demand for cancer vaccines.

Secure Your Global Cancer Vaccines Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Which Key Market Segments Comprise the Cancer Vaccines Market and Drive Its Revenue Growth?

The cancer vaccines market covered in this report is segmented –

1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types

4) By End-User: Cancer Treatment Centers, Research Institutes

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines

2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines

What Regions Are Steering Growth in the Cancer Vaccines Sector?

The countries covered in the cancer vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

How Is the Cancer Vaccines Market Classified and Defined in Market Analysis?

Cancer vaccines refer to cancer-treatment vaccinations and medications that aid the body in illness prevention and cancer treatment. They have the power to teach the immune system to recognize and eliminate dangerous microbes and cells.

Browse Through More Similar Reports By The Business Research Company:

Cancer biologics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

February 27, 2025
Future Outlook of the Global Cancer Vaccines Market 2024-2033: Size and Growth Rate Predictions

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

Cancer Vaccines Market: What is the Projected CAGR for 2024-2033?

In the past few years, the size of the cancer vaccines market has seen swift expansion. The market is projected to increase from $7.22 billion in 2023 to $8.25 billion in 2024, achieving a compound annual growth rate (CAGR) of 14.3%. The immense growth during the historic period is due to a combination of factors including a surge in cancer cases, heightened awareness about cancer vaccines, expanding portfolio of approved cancer vaccines, and burgeoning evidence supporting the effectiveness of these vaccines, supplemented by governmental backing for research and development efforts.

The market size of cancer vaccines is projected to experience swift expansion in the upcoming years. The projected growth is estimated to reach a value of $13.89 billion in 2028, with a compound annual growth rate (CAGR) of 13.9%. Factors contributing to the anticipated growth within this period include the integration of cancer vaccines with other therapies, increased funding from pharmaceutical firms, the emergence of biomarkers, customised vaccines, and the expansion of immunization programs. The forecast period also points towards significant trends such as advancements in the field of immunology, auxiliary treatments, diversification of indications, improved access for patients, collaborative studies, neoantigen-focused vaccines, and therapeutic vaccines for cancer.

Claim Your Free Sample of the Global Cancer Vaccines Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

What Are the Primary Drivers Supporting the Growth of the cancer vaccines Market?

The global rise in cancer cases is predicted to enhance the expansion of the cancer vaccines market throughout the forecasted timeline. For example, as per the American Cancer Society’s January 2022 statistics, it is expected that 1.9 million novel cancer cases and 609,360 deaths owing to cancer will occur in the US, which translates to about 1,670 deaths daily. Lung, prostate, bowel, and female breast cancer, which are the four most prevailing cancer types around the globe, make up 43 percent of all new cancer diagnoses. Consequently, this upward trend in global cancer incidence is expected to stimulate the demand for the cancer vaccine market in the next few years.

What Are the Core Segments of the Cancer Vaccines Market?

1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types

4) By End-User: Cancer Treatment Centers, Research Institutes

What Trends Are Paving the Way for Change in the Cancer Vaccines Market?

Investments in preventive, or prophylactic, cancer vaccines are surging within the cancer vaccine industry. These vaccines work to enhance immunity in patients by introducing antigens into their body. Cervical cancer – the second most prevalent cancer in women, as cited by the World Health Organization – makes up 84% of new cancer cases globally. Presently, three HPV vaccines have been developed for the prevention of cancer. Two of these vaccines effectively combat HPV 16 and HPV 18, responsible for 70% of cervical cancer cases. An additional vaccine combats three more oncogenic HPV types responsible for a further 20% of cervical cancer incidences. These vaccines include Merck’s Gardasil and Gardasil 9, and GSK’s Cervarix.

Order Now for Fast Delivery of Your Cancer Vaccines Market Report!

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Which Regions Are Leading the Charge in Cancer Vaccines Market Development?

North America was the largest region in the cancer vaccines market in 2023. The regions covered in the cancer vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The Cancer Vaccines Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cancer vaccines market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Cancer Vaccines Market Include

1. Cancer Vaccines Market Executive Summary

2. Cancer Vaccines Market Segments

3. Cancer Vaccines Market Size And Template Market Growth Rate

4. Key Cancer Vaccines Market Trends

5. Major Cancer Vaccines Market Drivers

……

25. Key Mergers And Acquisitions In The Cancer Vaccines Market

26. Top Cancer Vaccines Companies

27. Cancer Vaccines Market Opportunities And Strategies

28. Cancer Vaccines Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Therapeutic Proteins Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Vaccine Adjuvants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

December 10, 2024
Global Cancer Vaccines Market Report 2024 – Top Market Trends And Opportunities
The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The cancer vaccines market size has grown rapidly in recent years. It will grow from $7.22 billion in 2023 to $8.25 billion in 2024 at a compound annual growth rate (CAGR) of 14.3%. Let’s delve into the factors fueling this growth and what the forecast holds for the future.

Rising Cancer Cases Drive Demand For Cancer Vaccines
- The rise in cancer cases across the globe contributes to market growth.
- Globally, lung, prostate, bowel, and female breast cancer account for 43% of all new cancer cases.
- The anticipated increase in cancer incidence rates globally boosts the demand for cancer vaccines.
- Major companies operating in the market include GlaxoSmithKline PLC, Merck & Co. Inc., and AstraZeneca PLC.
Quadrivalent Vaccines Gain Traction In The Cancer Vaccines Market
- Major companies focus on introducing quadrivalent vaccines to maximize revenue.
- Serum Institute of India launched CERVAVAC, the first made-in-India cervical cancer vaccine, targeting HPV types responsible for at least 70% of cervical cancers.
- Quadrivalent vaccines are designed to protect against four different strains or types of a specific virus or bacteria.
Read More On The Cancer Vaccines Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

NEC OncoImmunity Strengthens Cancer Therapy Portfolio
- In March 2022, NEC OncoImmunity acquired neoantigen vaccine development assets from Vaximm AG, enhancing its AI-optimized personalized cancer therapies.
- Vaximm AG manufactures vaccines and T-cell immunotherapies for cancer patients.
Segmentation Insights
The cancer vaccines market is segmented by type, technology, cancer type, and end-user:
1. By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
2. By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines
3. By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types
4. By End-User: Cancer Treatment Centers, Research Institutes
North America Leads the Way
- North America dominated the cancer vaccines market in 2023.
Forecasting the Future
The cancer vaccines market is expected to witness significant growth in the next few years. It will reach $13.89 billion in 2028 at a compound annual growth rate (CAGR) of 13.9%. Here’s what drives this forecasted growth:
- Combination therapies with cancer vaccines.
- Increased investment from pharmaceutical companies.
- Emerging biomarkers and personalized vaccines.
- Expanding vaccination programs.
Emerging Trends
The forecast period also brings forth several trends:
- Advancements in immunology and adjuvant therapies.
- Diversification of indications and enhanced patient access.
- Collaborative research initiatives and neoantigen-based vaccines.
- Therapeutic cancer vaccines pave the way for a promising future.
Final Thoughts
The landscape of cancer vaccines is evolving rapidly, driven by advancements in technology, rising cancer cases, and strategic collaborations among key players. As the market continues to expand, innovations in preventive and therapeutic vaccines hold the promise of revolutionizing cancer treatment and prevention globally. The forecasted growth underscores the urgency and importance of continued research and investment in this critical area of healthcare. As we navigate through the complexities of cancer treatment, the development and adoption of vaccines stand as beacons of hope in our collective fight against this formidable disease.

Request for A Sample Of The Global Cancer Vaccines Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=3452&type=smp
March 5, 2024